Cited by 337Drug Transport and Resistance MechanismsPharmacogenetics and Drug MetabolismProtein Interaction Studies and Fluorescence Analysis

The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.

EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS

Shitara, Yoshihisa, Sato, Hitoshi, Sugiyama, Yuichi·2005·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.44.101802.121444

Open this paper in CoChat — free account

Abstract

Recent studies have revealed the import role played by transporters in the renal and hepatobiliary excretion of many drugs. These transporters exhibit a broad substrate specificity with a degree of overlap, suggesting the possibility of transporter-mediated drug-drug interactions with other substrates. This review is an overview of the roles of transporters and the possibility of transporter-mediated drug-drug interactions. Among the large number of transporters, we compare the Ki values of inhibitors for organic anion transporting polypeptides (OATPs) and organic anion transporters (OATs) and their therapeutic unbound concentrations. Among them, cephalosporins and probenecid have the potential to produce clinically relevant OAT-mediated drug-drug interactions, whereas cyclosporin A and rifampicin may trigger OATP-mediated ones. These drugs have been reported to cause drug-drug interactions in vivo with OATs or OATP substrates, suggesting the possibility of transporter-mediated drug-drug interactions. To avoid adverse consequences of such transporter-mediated drug-drug interactions, we need to be more aware of the role played by drug transporters as well as those caused by drug metabolizing enzymes.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.44.101802.121444

Cites

199 of 199 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T. A., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,372
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 819
Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene
Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C., Otter, M. Y., Scheffer, G. L., Scheper, R. J., Borst, P., & Elferink, R. P. J. O. (1996) · Science · doi:10.1126/science.271.5252.1126 · Cited by 817
A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 798
Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
Pang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059688 · Cited by 797
Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance
König, J., Nies, A. T., Cui, Y., Leier, I., & KEPPLER, D. O. R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00169-8 · Cited by 786
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K. E., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 718
Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2
Tamai, I., Ohashi, R., Nezu, J., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20378 · Cited by 696

Show all 199 references

Research works printed but not linked: 52

Pang KS, 1978, J. Pharmacol. Exp. Ther., 207, 178
Lecureur V, 2000, Mol. Pharmacol., 57, 24
Yamazaki M, 2001, J. Pharmacol. Exp. Ther., 296, 723
Walle UK, 1998, Drug Metab. Dispos., 26, 343
Tanigawara Y, 1992, J. Pharmacol. Exp. Ther., 263, 840
Zhang L, 1998, J. Pharmacol. Exp. Ther., 286, 354
Yabuuchi H, 1999, J. Pharmacol. Exp. Ther., 289, 768
Wu X, 1999, J. Pharmacol. Exp. Ther., 290, 1482
Ohashi R, 1999, J. Pharmacol. Exp. Ther., 291, 778
Nakai D, 2001, J. Pharmacol. Exp. Ther., 297, 861
Ishizuka H, 1998, J. Pharmacol. Exp. Ther., 287, 37
Hosokawa S, 1992, Lab. Animal Sci., 42, 27
Muller M, 1997, Am. J. Physiol., 272, G1285
10.1016/0304-4157(95)00006-D · DOI
Taniguchi K, Cancer Res., 56, 4124
Kuwano M, 1999, Anticancer Drug Des., 14, 123
Niinuma K, 1999, Am. J. Physiol, 276, G1153
Cui Y, 1999, Mol. Pharmacol., 55, 929
Niinuma K, 1999, Am. J. Physiol, 276, G1153
Hooijberg JH, 1999, Cancer Res., 59, 2532
Zeng H, 2000, Cancer Res., 60, 4779
Allikmets R, 1998, Cancer Res., 58, 5337
Miyake K, 1999, Cancer Res., 59, 8
Maliepaard M, 2001, Cancer Res., 61, 3458
Akhteruzzaman S, 1999, J. Pharmacol. Exp. Ther., 290, 1107
Madan A, 1999, Drug Metab. Dispos., 27, 327
Kouzuki H, 1998, J. Pharmacol. Exp. Ther., 286, 1043
Kouzuki H, 1999, J. Pharmacol. Exp. Ther, 288, 627
Ito K, 1998, Pharmacol. Rev., 50, 387
Ueda K, 2001, J. Pharmacol. Exp. Ther., 297, 1036
Masuda S, 1997, J. Pharmacol. Exp. Ther., 283, 1039
Masuda S, 1999, Mol. Pharmacol., 55, 743
Takeuchi A, 2001, J. Pharmacol. Exp. Ther., 299, 261
Chu XY, 1997, J. Pharmacol. Exp. Ther., 281, 304
Gupta E, 1994, Cancer Res., 54, 3723
Regazzi MB, 1993, Transplant. Proc., 25, 2732
Hasunuma T, 2003, J. Clin. Ther. Med., 19, 381
10.1345/aph.1A116 · DOI
Mueck W, 2001, AAPS PharmSci., 3, 3566
Sallustio BC, 1996, Drug Metab. Dispos., 24, 984
Sabordo L, 1998, J. Pharmacol. Exp. Ther., 288, 414
Sabordo L, 2000, J. Pharmacol. Exp. Ther., 295, 44
Olinga P, 1998, J. Pharmacol. Exp. Ther., 285, 506
Marino EL, 1981, Int. J. Clin. Pharmacol. Ther. Toxicol., 19, 506
Kremer JM, 1995, J. Rheumatol., 22, 2072
Apiwattanakul N, 1999, Mol. Pharmacol., 55, 847
Morita N, 2001, J. Pharmacol. Exp. Ther., 298, 1179
Jariyawat S, 1999, J. Pharmacol. Exp. Ther, 290, 672
Uwai Y, 2000, J. Pharmacol. Exp. Ther., 295, 261
Cvetkovic M, 1999, Drug Metab. Dispos., 27, 866
Bossuyt X, 1996, J. Pharmacol. Exp. Ther., 276, 891–96
Sugiyama D, 2001, J. Pharmacol. Exp. Ther., 298, 316–22

Sorted by citations

Items 201–300 of 337

Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer
Kobayashi, M., Tsujiuchi, T., Okui, Y., Mizutani, A., Nishi, K., Nakanishi, T., Nishii, R., Fukuchi, K., Tamai, I., & Kawai, K. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2548-5 · Cited by 14
Regulation of Organic Anion Transporting Polypeptide 2B1 Expression by MicroRNA in the Human Liver
Tajiri, A., Hirota, T., Kawano, S., Yonamine, A., & Ieiri, I. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00193 · Cited by 14
Kinetic analysis of saturable hepatic uptake of digoxin and its inhibition by rifampicin
Weiß, M., Hung, D. Y., Poenicke, K., & Roberts, M. S. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.05.007 · Cited by 14
A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions
Cherkaoui‐Rbati, M. H., Paine, S. W., Littlewood, P., & Rauch, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183794 · Cited by 16
Characterizing Metabolic Inhibition Using Electrochemical Enzyme/DNA Biosensors
Hull, D. O., Bajrami, B., Jansson, I., Schenkman, J. B., & Rusling, J. F. (2008) · Analytical Chemistry · doi:10.1021/ac802179s · Cited by 14
Statin response and pharmacokinetics variants
Kajinami, K., Masuya, H., Hoshiba, Y., Takeda, K., Sato, R., Okabayashi, M., & Schaefer, E. J. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.8.1291 · Cited by 14
Carvacrol Exerts Anti-Inflammatory, Anti-Oxidative Stress and Hepatoprotective Effects against Diclofenac-Induced Liver Injury in Male Rats
Barzan, M., Heydari, M., Jahangiri, H. M., Firouzi, H., Dastan, M., Najafi, M., Khaledi, M., Nouri, A., & Shah-abadi, M. E. (2023) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_178_21 · Cited by 13
Molecular Mechanisms of Biliary Excretion of Cefditoren and the Effects of Cefditoren on the Expression Levels of Hepatic Transporters
Meng, Q., Liu, Q., Wang, C., Sun, H., Kaku, T., Kato, Y., & Liu, K. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-09-rg-092 · Cited by 13
Amino-terminal region of human organic anion transporting polypeptide 1B1 dictates transporter stability and substrate interaction
Wang, X., Chen, J., Xu, S., Ni, C., Fang, Z., & Hong, M. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114642 · Cited by 13
Probe ADME and Test Hypotheses: a PATH beyond clearancein vitro–in vivocorrelations in early drug discovery
Bell, L., & Wang, J. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.695346 · Cited by 12
Ipratropium is ‘luminally recycled’ by an inter-play between apical uptake and efflux transporters in Calu-3 bronchial epithelial cell layers
Panduga, V., Stocks, M. J., & Bosquillon, C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.112 · Cited by 12
Intestinal metabolites, chronic kidney disease and renal transplantation: Enigma Variations?
Vanholder, R. C., Glorieux, G., & Massy, Z. A. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw040 · Cited by 12
Low‐dose probenecid selectively inhibits urinary excretion of phenolsulfonphthalein in rats without affecting biliary excretion
Shin, Y., Lee, J. H., Oh, J., & Lee, Y. J. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1778 · Cited by 12
Clinical Trials—Collecting Safety Data and Establishing the Adverse Drug Reactions Profile
Talbot, J. C. C., Keisu, M., & Ståhle, L. (2011) · Wiley eBooks · doi:10.1002/9780470975053.ch4 · Cited by 12
Cytochrome P450 Enzymes, Drug Transporters and their Role in Pharmacokinetic Drug-Drug Interactions of Xenobiotics: A Comprehensive Review
Srinivas, M. (2017) · doi:10.17352/pjmcr.000006 · Cited by 11
Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models
Kapitulnik, J., Pelkonen, O., Gundert‐Remy, U., Dahl, S. G., & Boobis, A. R. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903018965 · Cited by 11
Effects of P-glycoprotein on the intestine and blood-brain barrier transport of YZG-331, a promising sedative-hypnotic compound
Liu, Z., Mi, J., Yang, S. C., Zhao, M., Li, Y., & Li, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.039 · Cited by 11
Interpretation of drug concentrations in an alternative matrix: the case of meprobamate in bile
Fanton, L., Bévalot, F., Gustin, M., Paultre, C. Z., Meur, C. L., & Malicier, D. (2008) · International Journal of Legal Medicine · doi:10.1007/s00414-008-0259-x · Cited by 11
Flavonoids and Drug Interactions
Yáñez, J. A., Chemuturi, N. V., Womble, S. W., Sayre, C. L., & Davies, N. M. (2012) · doi:10.1002/9781118468524.ch7 · Cited by 11
Transmembrane Domain 1 of Human Organic Anion Transporting Polypeptide 2B1 Is Essential for Transporter Function and Stability
Fang, Z., Huang, J., Chen, J., Xu, S., Xiang, Z., & Hong, M. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.111914 · Cited by 10
Overcoming the shortcomings of the extended-clearance concept: a framework for developing a physiologically-based pharmacokinetic (PBPK) model to select drug candidates involving transporter-mediated clearance
Liang, X., & Lai, Y. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1912012 · Cited by 10
In vivo relevance of Mrp2-mediated biliary excretion of the Amanita mushroom toxin demethylphalloin
Gavrilova, O., Geyer, J., & Petzinger, E. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.07.006 · Cited by 10
The Biology and Function of Transporters
Scherrmann, J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00123-1 · Cited by 10
A Pharmaceutical Industry Perspective on Transporter and CYP-Mediated Drug–Drug Interactions: Kidney Transporter Biomarkers
Shen, H. (2018) · Bioanalysis · doi:10.4155/bio-2017-0265 · Cited by 10
Cloning and functional characterization of the pig (Sus scrofa) organic anion transporting polypeptide 1a2
Yu, Y., Liu, X., Zhang, Z., Xiao, Y., & Hong, M. (2013) · Xenobiotica · doi:10.3109/00498254.2012.760762 · Cited by 9
Drug–Drug Interactions within Protein Cavities Probed by Triplet–Triplet Energy Transfer
Nuin, E., Jiménez, M. C., Sastre, G., Andreu, I., & Miranda, M. A. (2013) · The Journal of Physical Chemistry Letters · doi:10.1021/jz400640s · Cited by 9
Gold nanoparticles based sensor for in vitro analysis of drug-drug interactions using imipramine and isoniazid drugs: A proof of concept approach
Shaikh, T., Pandey, A. K., Uddin, S., Talpur, F. N., Kaushik, A. C., & Niazi, J. H. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.06.083 · Cited by 9
Inhibitory Effect of Selective Cyclooxygenase-2 Inhibitor Lumiracoxib on Human Organic Anion Transporters hOAT1 and hOAT3
Uwai, Y., Honjo, H., & Iwamoto, K. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rg-048 · Cited by 9
Transport-Metabolism Interplay of Atazanavir in Rat Hepatocytes
Nicolaï, J., de Bruyn, T., Thevelin, L., Augustijns, P., & Annaert, P. (2016) · Drug Metabolism And Disposition · doi:10.1124/dmd.115.068114 · Cited by 9
Principles and Experimental Considerations for In Vitro Transporter Interaction Assays
Bhoopathy, S., Bode, C., Naageshwaran, V., Weiskircher-Hildebrandt, E. A., & Hidalgo, I. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-758-7_12 · Cited by 9
Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and l-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells
Taghikhani, E., Maas, R., Taudte, R. V., Gessner, A., Fromm, M. F., & König, J. (2020) · Amino Acids · doi:10.1007/s00726-020-02867-8 · Cited by 9
Investigation of Drug–Drug Interactions Between Ritobegron, a Selective β3‐Adrenoceptor Agonist, With Probenecid in Healthy Men
Abe, Y., Nakano, Y., Kanazawa, T., Furihata, T., Endo, T., & Kobayashi, M. (2015) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.212 · Cited by 8
Effects of capsaicin on pharmacokinetics of pitavastatin in rats
Chen, F., Zhai, X., Zhu, C., & Lu, Y. (2014) · Xenobiotica · doi:10.3109/00498254.2014.956848 · Cited by 8
How we have learned about the complexity of physiology, pathobiology and pharmacology of bile acids and biliary secretion
Marín, J. J. G. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5617 · Cited by 8
Radiosynthesis of novel pitavastatin derivative ([18F]PTV‐F1) as a tracer for hepatic OATP using a one‐pot synthetic procedure
Kimura, H., Yagi, Y., Arimitsu, K., Maeda, K., Ikejiri, K., Takano, J., Kusuhara, H., Kagawa, S., Ono, M., Sugiyama, Y., et al. (2016) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3464 · Cited by 8
Self-citation
Transporters – The View from Industry
Kohl, C. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900150 · Cited by 8
Identification of a NFκB Inhibition Site on the Proximal Promoter Region of Human Organic Anion Transporting Polypeptide 1A2 Coding Gene SLCO1A2
Xiang, Z., Li, W., Wang, L., Yi, J., Chen, K., & Hong, M. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078832 · Cited by 7
The Clinical Significance of Drug Transporters in Drug Disposition and Drug Interactions
Thompson, T. N. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7937-7_13 · Cited by 7
Drug Interactions
Robertson, S. M. C., & Penzak, S. R. (2007) · Elsevier eBooks · doi:10.1016/b978-012369417-1/50055-9 · Cited by 8
Hepatic Clearance Prediction of Nine Human Immunodeficiency Virus Protease Inhibitors in Rat
Bruyn, T. D., Augustijns, P., & Annaert, P. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24559 · Cited by 7
Quantitative Structure–Activity Relationship Analysis of a Series of Human Renal Organic Anion Transporter Inhibitors
Wei, Y., Xi, L., Yao, X., Li, J., & Wu, X. (2012) · Archiv der Pharmazie · doi:10.1002/ardp.201200088 · Cited by 6
Mechanisms of altered hepatic drug disposition during pregnancy: small molecules
Fashe, M. M., Tiley, J. B., & Lee, C. R. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2470792 · Cited by 7
In Vitro Characterization of Interactions with Drug Transporting Proteins
Artursson, P., Matsson, P., & Karlgren, M. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-8229-1_3 · Cited by 6
Effect of X-ray irradiation on expression of organic anion transporting polypeptides
Zhan, K., Yao, J., Huang, J., Zhou, G., Li, W., Chen, L., & Hong, M. (2013) · International Journal of Radiation Biology · doi:10.3109/09553002.2013.784427 · Cited by 6
Drug Interactions
Robertson, S. M. C., Penzak, S. R., & Huang, S. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385471-1.00015-5 · Cited by 6
Long-Lasting Inhibition of the Intestinal Absorption of Fexofenadine by Cyclosporin a in Rats
Suzuki, K., Shitara, Y., Fukuda, K., & Horie, T. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23174 · Cited by 6
Self-citation
Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in humans and Oatp1a1, Oatp1a4, and Oatp1b2 in rats
Wang, H., Sun, P., Wang, C., Meng, Q., Liu, Z., Huo, X., Sun, H., Ma, X., Peng, J., & Liu, K. (2017) · RSC Advances · doi:10.1039/c7ra03537c · Cited by 6
Cytochrome P450 enzymes— in vitro , in vivo , and in silico studies
Turpeinen, M. (2006) · Cited by 6
Understanding Coproporphyrins and Their Disposition: Coproporphyrinuria is Common, of Diverse Cause, and Rarely Indicates Porphyria
Bonkovsky, H. L., Ma, C. D., Araque, M., Tiley, J. B., Brouwer, K. L. R., & Stölzel, U. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.04.004 · Cited by 5
Obesity-related drug transporter expression alterations in human liver and kidneys
Kosicka, K., Romaniuk-Drapała, A., Sheng, Y.-H., Yohn, C. N., Brunetti, L., & Kagan, L. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00665-7 · Cited by 5
Interaction of swine organic anion transporting polypeptide 1a2 with tetracycline, macrolide and β-lactam antibiotics
Lin, X., Xiang, Z., Wang, B., Chen, H., Zhou, T., & Hong, M. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114649 · Cited by 5
Use of clearance concepts and modeling techniques in the prediction of metabolic drug–drug interactions
Ito, K., & Sugiyama, Y. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.05.002 · Cited by 5
Self-citation
Characterization of renal tubular apical efflux of zonampanel, anα-amino-3-hydroxy-5- methylisoxazole-4-propionate receptor antagonist, in humans
Minematsu, T., HASHIMOTO, T., Usui, T., & Kamimura, H. (2008) · Xenobiotica · doi:10.1080/00498250802187286 · Cited by 5
Population pharmacokinetic modeling of cefadroxil renal transport in wild-type andPept2knockout mice
Xie, Y., Shen, H., Hu, Y., Feng, M. R., & Smith, D. E. (2015) · Xenobiotica · doi:10.3109/00498254.2015.1080881 · Cited by 5
General Principles of Drug Distribution
Wallace, G., Ramsden, D., & Grant, M. H. (2012) · Encyclopedia of Drug Metabolism and Interactions · doi:10.1002/9780470921920.edm024 · Cited by 5
Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats
Hu, J., Liu, X., Xie, L. Y., Wang, G. J., & Liu, H. Y. (2007) · Xenobiotica · doi:10.1080/00498250701358731 · Cited by 4
Absorption, Enterohepatic Circulation, and Fecal Excretion of Toxicants
Watkins, J. B., & Klaassen, C. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00847-2 · Cited by 4
Modeling and Simulation of Pharmacokinetic Aspects of Cytochrome P450-Based Metabolic Drug–Drug Interactions
Dickins, M., Galetin, A., & Proctor, N. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00152-8 · Cited by 4
The Role of Permeability in Drug ADME / PK , Interactions and Toxicity, and the Permeability‐Based Classification System ( PCS )
Fagerholm, U. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc163 · Cited by 4
Hepatic Transport
Maeda, K., Suzuki, H., & Sugiyama, Y. (2008) · Methods and principles in medicinal chemistry · doi:10.1002/9783527623860.ch11 · Cited by 4
Self-citation
Differences in the Pharmacokinetics of 4-Amino-3-Chlorophenyl Hydrogen Sulfate, a Metabolite of Resatorvid, in Rats and Dogs
Jinno, F., Takeuchi, T., Tagawa, Y., Kondo, T., Itoh, T., & Asahi, S. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.043729 · Cited by 3
A Review on Drug Interactions in Oral Hypoglycemic Drugs by Mechanism of Cytochrome P450 Enzyme Inhibition
Mrudula, G., Caroline, P., Kingsley, T., & Jaiswal, R. (2017) · Journal of Pharmaceutical Research · doi:10.18579/jpcrkc/2017/16/2/116434 · Cited by 3
Drug-Induced Liver Injury Predictions: Extended Clearance Model and Its Use for Prospective Transporter and Enzyme-Based Hepatic Cell Stress Grading
Camenisch, G. (2019) · International Journal of Pharmacy and Chemistry · doi:10.11648/j.ijpc.20190502.11 · Cited by 3
Web-Based Database as a Tool to Examine Drug–Drug Interactions Involving Transporters
Maeda, K., Shitara, Y., Horie, T., & Sugiyama, Y. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0840-7_16 · Cited by 3
Self-citation
Principles and Experimental Considerations for In Vitro Transporter Interaction Assays
Bhoopathy, S., Bode, C., Naageshwaran, V., Weiskircher-Hildebrandt, E. A., Mukkavilli, V. M., & Hidalgo, I. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1554-6_13 · Cited by 3
Species differences of organic anion transporters involved in the renal uptake of 4‐amino‐3‐chlorophenyl hydrogen sulfate, a metabolite of resatorvid, between rats and dogs
Takeuchi, T., Jinno, F., Ebihara, T., Moriya, Y., Kadotani, R., Tagawa, Y., Kondo, T., Itoh, T., & Asahi, S. (2013) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1841 · Cited by 3
Active Renal Secretion of NXY‐059, a Novel Neuroprotectant, Is Mediated via an Organic Acid Transporter
Cheng, Y., Strid, S., Borgå, O., Nilsson, D., & Wemer, J. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007301803 · Cited by 3
Acompanhamento farmacoterapêutico em pacientes dislipidêmicos de um lar de idosos da cidade de Novo Hamburgo-RS
de Gregori, F., Ziulkoski, A. L., Andrighetti, L. H., Lourenço, E. D., & Perassolo, M. S. (2013) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/s1809-98232013000100017 · Cited by 3
Psychological Symptoms Associated with Cardiovascular Drugs; Cardiac Symptoms from Psychiatric Drugs; Drug Interactions
Erickson, S. R., Bostwick, J. R., & Guthrie, S. K. (2011) · Wiley eBooks · doi:10.1002/9780470975138.ch15 · Cited by 3
The Hepatocyte and the Cancer Cell: Dr Jekyll and Mr Hyde
Gillet, J., Gottesman, M. M., & Okabe, M. (2009) · doi:10.1002/9780470747919.ch66 · Cited by 3
Simplifying the Extended Clearance Concept Classification System (EC3S) to Guide Clearance Prediction in Drug Discovery
Patel, M., Riede, J., Bednarczyk, D., Poller, B., & Deshmukh, S. V. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03482-4 · Cited by 2
Drug Interactions of Antiarrhythmic Drugs
Caballero, R., Delpón, E., & Tamargo, J. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-74046-6_10 · Cited by 2
The basics of pharmacokinetics in prescribing and clinical practice
Khan, E. U. (2011) · Nurse Prescribing · doi:10.12968/npre.2011.9.11.557 · Cited by 2
Pharmacokinetics and Pharmacodynamics
Khan, E. (2020) · Springer eBooks · doi:10.1007/978-3-030-32004-1_2 · Cited by 2
Drug Transport Mechanisms and their Impact on the Disposition and Effects of Drugs
Scherrmann, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-417205-0.00026-2 · Cited by 2
Inhibitory effect of medicinal plant-derived carboxylic acids on the human transporters hOAT1, hOAT3, hOATP1B1, and hOATP2B1
Zhang, Z., Si, D., Yi, X., & Liu, C. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60021-2 · Cited by 2
Disposition of ON 01210.Na (Ex-RAD(R)), a Novel Radioprotectant, in the Isolated Perfused Rat Liver: Probing Metabolic Inhibition to Increase Systemic Exposure
Tamhane, M., Maniar, M. L., Ren, C., Benzeroual, K. E., & Taft, D. R. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23391 · Cited by 2
Transporter-Based Drug–Drug Interactions and Their Effect on Distribution Volumes
Grover, A., & Benet, L. Z. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0840-7_18 · Cited by 2
Mechanisms of Bile Secretion
Jansen, P. L. M., & Groen, A. K. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50010-3 · Cited by 2
Extrapolation of In Vitro Metabolic and P-Glycoprotein-Mediated Transport Data to In Vivo by Modeling and Simulations
Kato, M., Shitara, Y., Kitajima, M., Tachibana, T., Ishigai, M., Horie, T., & Sugiyama, Y. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0840-7_12 · Cited by 2
Self-citation
Absorption, Enterohepatic Circulation, and Fecal Excretion of Toxicants
Watkins, J. B., & Klaassen, C. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02122-x · Cited by 2
The intracellular NPxY motif is critical in maintaining the function and expression of human organic anion transporting polypeptide 1B1
Wang, X., Liang, Y., Fang, Z., Huang, J., & Hong, M. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.04.001 · Cited by 2
Imaging of hepatic drug transporters with [131I]6-β-iodomethyl-19-norcholesterol
Kobayashi, M., Nishi, K., Mizutani, A., Hokama, T., Matsue, M., Tsujikawa, T., Nakanishi, T., Nishii, R., Tamai, I., & Kawai, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-50049-8 · Cited by 2
Pharmacogenetics of SLCO1B1 : Population genetics and effect on statins
Pasanen, M. K. (2008) · Työväentutkimus Vuosikirja · Cited by 2
DDI Risk Assessment and Evaluation in Pharmaceutical Development: Interfacing Drug Metabolism and Clinical Pharmacology
Venkatakrishnan, K. (2012) · Encyclopedia of Drug Metabolism and Interactions · doi:10.1002/9780470921920.edm118 · Cited by 2
Strategies to assess the drug interaction potential in translational medicine
Persiani, S., & Larger, P. J. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.5.675 · Cited by 2
The Extended Clearance Model
Poller, B., Huth, F., Kastrinou‐Lampou, V., Kullak-Ublick, G. A., Arand, M., & Camenisch, G. (2021) · Wiley eBooks · doi:10.1002/9781119171003.ch15 · Cited by 2
Renal Drug Excretion
Talevi, A., & Bellera, C. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-84860-6_73 · Cited by 2
Drug Excretion
Barreto, E. F., Larson, T. R., & Koubek, E. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00004-9 · Cited by 1
Drug-drug interactions in ageing HIV-infected individuals
Fasinu, S. (2012) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp12.487 · Cited by 1
Industrial Evaluation of Drug Transporters in ADME
Taub, M. E., Ishiguro, N., Schaefer, O., & Tweedie, D. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-8229-1_12 · Cited by 1
Structure‐dependent relative toxic potencies of selected pyrrolizidine alkaloids
Gao, L., & Schrenk, D. (2023) · Lebensmittelchemie · doi:10.1002/lemi.202352223 · Cited by 1
ABC-transportørenes betydning for effekt og omsetning av legemidler
Slåtsve, A., Ravna, A. W., Lysaa, R. A., & Sager, G. (2011) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.10.0675 · Cited by 1
Pharmacokinetic interactions of pioglitazone
Jaakkola, T. (2007) · Työväentutkimus Vuosikirja · Cited by 1
Regulatory Considerations in Metabolism‐ and Transporter‐Based Drug Interactions
Zhang, Y., Zhang, L., Strong, J. M., & Huang, S. M. (2011) · doi:10.1002/9781118067598.ch26 · Cited by 1
Clinical Drug–Drug Interactions
Deshmukh, S. V. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse118 · Cited by 1
Comparison of three in vitro models expressing the membrane drug transporter OATP1B1
Ulvestad, M. (2007) · NORA - Norwegian Open Research Archives · Cited by 1
Extended Clearance Classification System ( ECCS ) and its Utility in Predicting Clearance Rate‐Determining Step in Drug Discovery
El‐Kattan, A. F. (2017) · Wiley eBooks · doi:10.1002/9781118916926.ch8 · Cited by 1
TRANSPORTERS‐MEDIATED DRUG DISPOSITION—PHYSIOCHEMISTRY AND IN SILICO APPROACHES
Varma, M. V. S., El‐Kattan, A. F., & Lai, Y. (2022) · doi:10.1002/9781119739883.ch21 · Cited by 1
Renal Drug Excretion
Talevi, A., & Bellera, C. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_73-1 · Cited by 1

Authors: Shitara, Y., Sato, H., & Sugiyama, Y.
Affiliations: SHOWA Medical University (JP)
The University of Tokyo (JP)
ORCID: Sato, Hitoshi
Sugiyama, Yuichi
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2005-09-22
Volume: 45
Issue: 1
Pages: 689-723
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.44.101802.121444
OpenAlex: W2066382275
Cited by: 336
References: 199
Citations by year: 2026: 2 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 11 · 2020: 8 · 2019: 7 · 2018: 9 · 2017: 14 · 2016: 15 · 2015: 12 · 2014: 14 · 2013: 23 · 2012: 25
FWCI: 2.12
Type: journal article
Language: en
Open access: closed
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
Keywords: drug-drug interactions, drug transporters, renal drug excretion, organic anion transporting polypeptides, organic anion transporters, transporter inhibitors, Ki values, substrate specificity, probenecid, cephalosporins, cyclosporine, rifampicin, drug-metabolizing enzymes
MeSH terms: Animals, Biliary Tract, Biological Transport, Drug Evaluation, Drug Interactions, Pharmaceutical Preparations, Humans, Kidney, Liver

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks